Tác động của tập thể dục aerobic lên nhận thức và thể tích hippocamp ở bệnh Alzheimer: giao thức nghiên cứu của một thử nghiệm đối chứng ngẫu nhiên (Thử nghiệm FIT-AD)

World Health Organization: Dementia: a public health priority. 2012, Retrieved from [http://whqlibdoc.who.int/publications/2012/9789241564458_eng.pdf] American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th ed.) text revision (DSM-IV-TRTM). 2000, Washington, DC: American Psychiatric Association Yu F, Kolanowski A, Strumpf N, Eslinger P: Improving cognition and function through exercise intervention in Alzheimer's disease. J Nurs Scholarsh. 2006, 38 (4): 358-365. 10.1111/j.1547-5069.2006.00127.x. Birks J: Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006, 1. Art. No.:CD005593. doi:10.1002/14651858.CD005593 Adlard AP, Perreau VM, Pop V, Cotman CW: Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J of Neuroscience. 2004, 25: 4217-4221. Cotman CW, Berchtold NC: Physical activity and the maintenance of cognition: learning from animal models. Alzheimers Dement. 2007, 3 (Suppl 2): 30-37. Erickson KI, Kramer AF: Aerobic exercise effects on cognitive and neural plasticity in older adults. Br J Sports Med. 2009, 43 (1): 22-24. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L: Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008, 005381-doi:10.1002/14651858.CD005381.pub3 Colcombe S, Kramer AF: Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003, 14 (2): 125-130. 10.1111/1467-9280.t01-1-01430. Etnier J, Salazar W, Landers D, Petruzzello S, Han M, Nowell P: The influence of physical fitness and exercise upon cognitive functioning: a meta-analysis. J Sport and Exerc Psychol. 1997, 19 (3): 249-277. Etnier JL, Nowell PM, Landers DM, Sibley BA: A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res Rev. 2006, 52 (1): 119-130. 10.1016/j.brainresrev.2006.01.002. Smith P, Blumenthal J, Hoffman B, Cooper H, Strauman T, Welsh-Bohmer K, Sherwood A: Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med. 2010, 72 (3): 239-252. 10.1097/PSY.0b013e3181d14633. Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Craft S: Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010, 67 (1): 71-79. Heyn P, Abreu BC, Ottenbacher KJ: The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil. 2004, 85 (10): 1694-1704. 10.1016/j.apmr.2004.03.019. Scherder E, Van Paasschen J, Deijen J, Van Der Knokke S, Orlebeke J, Burgers I, Sergeant J: Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Mental Health. 2005, 9 (3): 272-280. 10.1080/13607860500089930. Williams P, Lord SR: Effects of group exercise on cognitive functioning and mood in older women. Australian New Zealand J Public Health. 1997, 21 (1): 45-52. 10.1111/j.1467-842X.1997.tb01653.x. Rolland Y, Rival L, Pillard F, Lafont C, Rivére D, Albaréde J, Vellas B: Feasibility of regular physical exercise for patients with moderate to severe Alzheimer disease. J Nutr Health Aging. 2000, 4 (2): 109-113. Palleschi L, Vetta F, De Gennaro E, Idone G, Scottosanti G, Gianni W, Marigliano V: Effect of aerobic training on the cognitive performance of elderly patients with senile dementia of Alzheimer type. Arch Gerontol Geriatrics. 1996, 5: 47-50. Yu F, Nelson NW, Savik K, Wyman JF, Dyskin M, Bronas UG: Affecting cognition and quality of life via aerobic exercise in Alzheimer's disease. West J Nurs Res. 2013, 35 (1): 24-38. 10.1177/0193945911420174. Yu F, Thomas W, Nelson NW, Bronas UG, Dysken M, Wyman J: Impact of a 6-month aerobic exercise on Alzheimer's symptoms. J Appl Gerontol. 2013, in press Kemoun G, Thibaud M, Roumagne N, Carette P, Albinet C, Toussaint L, Dugue B: Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dementia Geriatric Cogn Disord. 2010, 29 (2): 109-114. 10.1159/000272435. Steinberg M, Leoutsakos JS, Podewils LJ, Lyketsos C: Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the maximizing independence in dementia (MIND) study. Int J Geriatric Psychiatry. 2009, 24 (7): 680-685. 10.1002/gps.2175. Arkin SM: Alzheimer rehabilitation by students: Interventions and outcomes. Neuropsychological Rehabilitation. 2001, 11 (3–4): 273-317. Yu F: Guiding research and practice: a conceptual model for aerobic exercise training in Alzheimer's disease. Am J Alzheimers Dis Other Dementias. 2011, 26 (3): 184-194. 10.1177/1533317511402317. Arkin SM: Student-led exercise sessions yield significant fitness gains for Alzheimer's patients. Am J Alzheimers Disease Other Dementias. 2003, 18 (3): 159-170. 10.1177/153331750301800302. McCurry SM, Pike KC, Logsdon RG, Vitiello MV, Larson EB, Teri L: Predictors of short- and long-term adherence to a daily walking program in persons with Alzheimer's disease. A J Alzheimers Dis Other Dementias. 2010, 25 (6): 505-512. 10.1177/1533317510376173. Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, Vellas B: Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc. 2007, 55 (2): 158-165. 10.1111/j.1532-5415.2007.01035.x. Tappen RM, Roach KE, Applegate EB, Stowell P: Effect of a combined walking and conversation intervention on functional mobility of nursing home residents with Alzheimer disease. Alzheimer Dis Assoc Disord. 2000, 14 (4): 196-201. 10.1097/00002093-200010000-00002. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Larson EB: Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. J Am Med Assoc. 2003, 290 (15): 2015-2022. 10.1001/jama.290.15.2015. Williams CL, Tappen RM: Effect of exercise on mood in nursing home residents with Alzheimer's disease. Am J Alzheimers Dis Other Dementias. 2007, 22 (5): 389-397. 10.1177/1533317507305588. Williams CL, Tappen RM: Exercise training for depressed older adults with Alzheimer's disease. Aging Mental Health. 2008, 12 (1): 72-80. 10.1080/13607860701529932. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991, 82: 239-259. 10.1007/BF00308809. Jack CRJ, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Kokmen E: Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998, 51 (4): 993-999. 10.1212/WNL.51.4.993. Jack CRJ, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Members of the Alzheimer's Disease Cooperative Study (ADCS): Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008, 29 (9): 1285-1295. 10.1016/j.neurobiolaging.2007.03.004. Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Chui HC: Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005, 65 (4): 565-571. 10.1212/01.wnl.0000172913.88973.0d. Fox NC, Kennedy J: Structural imaging markers for therapeutic trials in Alzheimer’s disease. J Nutr Health Aging. 2009, 13 (4): 350-352. 10.1007/s12603-009-0040-y. Frisoni GB, Delacourte A: Neuroimaging outcomes in clinical trials in Alzheimer's disease. J Nutr Health Aging. 2009, 13 (3): 209-212. 10.1007/s12603-009-0060-7. Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E: Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?. Am J Psychiatr. 2005, 162 (4): 676-682. 10.1176/appi.ajp.162.4.676. Jack CRJ, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Weiner MW: The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008, 27 (4): 685-691. 10.1002/jmri.21049. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Rogers S: Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatr. 2003, 160 (11): 2003-2011. 10.1176/appi.ajp.160.11.2003. Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Perhach JL: Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease. Alzheimers Dement. 2011, 7 (4): 425-435. 10.1016/j.jalz.2010.09.003. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, Kramer AF: Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus. 2009, 19 (10): 1030-1039. 10.1002/hipo.20547. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kramer AF: Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011, 108 (7): 3017-3022. 10.1073/pnas.1015950108. Larson EB, Wang L: Exercise, aging, and Alzheimer disease. Alzheimer Dis Assoc Disord. 2004, 18 (2): 54-56. 10.1097/01.wad.0000126615.70030.70. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Moher D: SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013, 158 (3): 200-207. 10.7326/0003-4819-158-3-201302050-00583. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010, 4: 291-292. Welsh KA, Ballard E, Nash F, Raiford K, Harrell L: Issues affecting minority participation in research studies of Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 (Suppl 4): 38-48. Doraiswamy PM, Kaiser L, Bieber F, Garman RL: The Alzheimer's disease assessment scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease. Alzheimer Dis Assoc Disord. 2001, 15 (4): 174-183. 10.1097/00002093-200110000-00003. Grill JD, Karlawish J: Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther. 2010, 2: 34-10.1186/alzrt58. Alzheimer's Association: Alzheimer's disease facts and figures. 2013, [http://www.who.int/ictrp/network/trds/en/] American College of Sports Medicine: ACSM's Guidelines for Exercise Testing and Prescription (9th ed.). 2013, Baltimore, MD: Lippincott Williams and Wilkins Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Treatment Fidelity Workgroup of the NIH Behavior Change Consortium: Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004, 23 (5): 443-451. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatr. 1984, 141 (11): 1356-1364. Dale AM, Fischl B, Sereno MI: Cortical surface-based analysis. I. segmentation and surface reconstruction. NeuroImage. 1999, 9 (2): 179-194. 10.1006/nimg.1998.0395. Fischl B, Dale AM: Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000, 97 (20): 11050-11055. 10.1073/pnas.200033797. Jack CRJ, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Foster NL: Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement. 2011, 7 (4): 474-485. 10.1016/j.jalz.2011.04.007. Fox NC, Warrington EK, Rossor MN: Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet. 1999, 353 (9170): 2125-10.1016/S0140-6736(99)00496-1. Freeborough PA, Fox NC: The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging. 1997, 16 (5): 623-629. 10.1109/42.640753. Gunter JL, Shiung MM, Manduca A, Jack CR: Methodological considerations for measuring rates of brain atrophy. J Magn Reson Imaging. 2003, 18 (1): 16-24. 10.1002/jmri.10325. Jack CRJ, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Petersen RC: Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004, 62 (4): 591-600. 10.1212/01.WNL.0000110315.26026.EF. Jack CRJ, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Petersen RC: Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005, 65 (8): 1227-1231. 10.1212/01.wnl.0000180958.22678.91. Royall DR, Mahurin RK, Gray KF: Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc. 1992, 40 (12): 1221-1226. Grigsby J, Kaye K, Robbins LJ: Reliabilities, norms and factor structure of the behavioral dyscontrol scale. Percept Motor Skills. 1992, 74 (3): 883-892. 10.2466/pms.1992.74.3.883. Royall DR, Cordes JA, Polk M: CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 1998, 64 (5): 588-594. 10.1136/jnnp.64.5.588. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Morris JC: The Alzheimer's disease centers' uniform data set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009, 23 (2): 91-101. 10.1097/WAD.0b013e318191c7dd. Burns JM, Mayo MS, Anderson HS, Smith HJ, Donnelly JE: Cardiorespiratory fitness in early-stage Alzheimer disease. Alzheimer Dis Assoc Disord. 2008, 22 (1): 39-46. 10.1097/WAD.0b013e31815a9ddc. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992, 47 (12): 1019-1024. 10.1136/thx.47.12.1019. Solway S, Brooks D, Lacasse Y, Thomas S: A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001, 119 (1): 256-270. 10.1378/chest.119.1.256. McAuley E, Morris KS, Doerksen SE, Motl RW, Liang H, White SM, Rosengren K: Effects of change in physical activity on physical function limitations in older women: Mediating roles of physical function performance and self-efficacy. J Am Geriatr Soc. 2007, 55 (12): 1967-1973. 10.1111/j.1532-5415.2007.01469.x. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Wallace RB: A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994, 49 (2): M85-M94. 10.1093/geronj/49.2.M85. Gelinas I, Gauthier L, McIntyre M, Gauthier S: Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999, 53 (5): 471-481. 10.5014/ajot.53.5.471. Cummings J: The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997, 48 (Suppl 5): 10-16. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, DeKosky ST: Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatr Clin Neurosci. 2000, 12 (2): 233-239. 10.1176/appi.neuropsych.12.2.233. Tappen RM, Williams CL: Development and testing of the Alzheimer's disease and related dementias mood scale. Nurs Res. 2008, 57 (6): 426-435. 10.1097/NNR.0b013e31818c3dcc. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA: Cornell scale for depression in dementia. Biol Psychiatry. 1988, 23 (3): 271-284. 10.1016/0006-3223(88)90038-8. The Psychological Corporation: Wechsler Test of Adult Reading. 2001, New York: The Psychological Corporation Washburn R, Smith K, Jette A, Janney CA: The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol. 1993, 46 (2): 153-162. 10.1016/0895-4356(93)90053-4. Washburn R, McAuley E, Katula J, Mihalko S, Boileau R: The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999, 52: 643-651. 10.1016/S0895-4356(99)00049-9.